Skip to main content
. 2022 May 23;9:887978. doi: 10.3389/fnut.2022.887978

TABLE 3.

Participants and available data.

Outcome measure N total (active/placebo) % of completed (N = 60)
Q1 Daily symptom questionnaire 53 (29/24) 88%
Q2 Weekly quality of life questionnaire 53 (29/24) 88%
Q3 Weekly gastrointestinal symptom Q 60 (31/29) 100%
Cytokine analysis 43 (25/18) 72%
Stool microbiome analysis 57 (28/29) 95%

N, number; Q, questionnaire.